Lv71
4925 积分 2021-05-12 加入
Family-wise type I error rate control for an extended 2-in-1 design with graphical approach in oncology drug development
1小时前
已完结
2-in-1 adaptive design with dose optimization accounting for ranked dose response
1小时前
已完结
An adaptive seamless 2-in-1 design with biomarker-driven subgroup enrichment
1小时前
已完结
An extension to a 2-in-1 adaptive design with biomarker subpopulation selection
1小时前
已完结
Flexible seamless 2-in-1 design with sample size adaptation
1小时前
已完结
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity
1个月前
已完结
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial
2个月前
已完结
Sample size determination for cardiodynamic ECG assessment using the Concentration-QTc analysis method
2个月前
已完结
Ethics of Backfilling in Early-Phase Oncology Trials
2个月前
已完结
Robust meta‐analytic‐predictive priors in clinical trials with historical control information
2个月前
已完结
皖公网安备34019202002308
